Avalon Globocare Corp
Company Profile
Business description
Avalon Globocare Corp is a technology driven company with a focus on developing products and services that serve growing consumer health and technology markets. Through its AI-driven subsidiary, the company is advancing next-generation AI systems, including automated video generation, enterprise documentation, and workflow automation solutions. Its segments consist of a consumer health technology segment, through which it distributes the Keto Air breathalyzer device, a non-invasive consumer breathalyzer that measures ketosis levels and is sold in North America; and an artificial intelligence content technology segment, through which it develops and commercializes an AI-driven, short-form video generation platform.
Contact
4400 Route 9 South
Suite 3100
FreeholdNJ07728
USAT: +1 732 780-4400
Sector
Real Estate
Stock type
Cyclical
Industry
Real Estate Services
Fiscal Year End
31 December 2026
Employees
2
Stocks News & Analysis
stocks
Chart of the Week: Recent selloffs in this ASX sector opens doors to opportunity
stocks
ASX dividend champions: Stocks, ETFs and LICs
stocks
SpaceX’s IPO filing: Big spending, big losses
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,840.80 | 9.50 | -0.11% |
| CAC 40 | 8,086.00 | 31.42 | -0.39% |
| DAX 40 | 24,606.77 | 130.47 | -0.53% |
| Dow JONES (US) | 49,908.14 | 101.21 | -0.20% |
| FTSE 100 | 10,443.47 | 11.13 | 0.11% |
| HKSE | 25,386.52 | 264.60 | -1.03% |
| NASDAQ | 26,152.51 | 117.85 | -0.45% |
| Nikkei 225 | 61,684.14 | 1,879.73 | 3.14% |
| NZX 50 Index | 12,878.07 | 117.04 | 0.92% |
| S&P 500 | 7,407.43 | 25.54 | -0.34% |
| S&P/ASX 200 | 8,621.70 | 6.30 | -0.07% |
| SSE Composite Index | 4,077.28 | 84.91 | -2.04% |